Comparison of Pain Relief Post Knee Arthroscopy Using IPACK + Adductor Canal Block vs. Adductor Canal Block Alone - Trial NCT06265441
Access comprehensive clinical trial information for NCT06265441 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Group A will receive adductor canal block after spinal anesthesia under a high-frequency ultrasound guidance in which the adductor canal is identified and 20 ml of 0.25% bupivacaine will be injected
Interventional
procedure
Sponsor & Location
Ain Shams University
Timeline & Enrollment
N/A
Mar 01, 2024
Oct 01, 2024
Primary Outcome
Assessment of pain using the visual analogue scale (VAS) upon first ambulation after 8 hours from the completion of the surgical procedure and skin closure.
Summary
In this study, the invistigators aim to compare postoperative analgesia effectiveness between
 combined interspace between the popliteal artery and posterior capsule of the knee block
 (IPACK) and Adductor canal block vs. Adductor canal block alone after Arthroscopic knee
 surgeries focusing on VAS score assessment at 8 hours postoperative.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06265441
Non-Device Trial